Protara Therapeutics (TARA) Shares Issued (2013 - 2026)

Protara Therapeutics (TARA) recorded quarterly Shares Issued of $1.9 million in Q1 2026, up 9610.0% quarter-over-quarter from $20000.0 in Q3 2025, and up 194100.0% on a YoY basis from N/an in Q1 2025.

Protara Therapeutics (TARA) Shares Issued (2013 - 2026) Analysis & Trends

Protara Therapeutics' Shares Issued history runs 8 years deep, the most recent figure standing at $1.9 million for Q1 2026.

  • In Q1 2026, Shares Issued rose 194100.0% year-over-year to $1.9 million; the TTM figure through Mar 2026 stood at $2.0 million (up 46.64% YoY), while the FY2025 annual figure was $21000.0, down 84.44% from the prior year.
  • Shares Issued was $1.9 million for Q1 2026 at Protara Therapeutics, up from $20000.0 in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $1.9 million in Q1 2026 to a low of $1000.0 in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Issued (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn - -
2 Belite Bio 55,096.00 Bn 55,096.00 Bn - -
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn - 5.40 Mn
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn - -
6 Evaxion A 1,551.28 Bn 1,551.26 Bn - -
7 Psyence Biomedical 227.32 Bn 227.31 Bn - -
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn 27.00 Mn
9 Abivax 91.71 Bn 91.71 Bn - 26,927.15
10 Protara Therapeutics 216.35 Mn 216.35 Mn - 1.94 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.94 Mn
Mar 31, 2026 1.94 Mn
Sep 30, 2025 20,000.00
Sep 30, 2025 20,000.00
Mar 31, 2025 1,000.00
Mar 31, 2025 1,000.00
Dec 31, 2020 1.34 Mn
Dec 31, 2020 1.34 Mn
Mar 31, 2020 12.41 Mn
Mar 31, 2020 12.41 Mn
Dec 31, 2019 1.00
Dec 31, 2019 1.00
Dec 31, 2017 1,000.00
Dec 31, 2017 1,000.00
Jun 30, 2017 1.30 Mn
Jun 30, 2017 1.30 Mn
Mar 31, 2017 108,000.00
Mar 31, 2017 108,000.00
Dec 31, 2016 41,000.00
Dec 31, 2016 41,000.00